Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Invested Capital (2016 - 2019)

Historic Return on Invested Capital for Pharma (IGC) over the last 11 years, with Q4 2019 value amounting to 0.2%.

  • Pharma's Return on Invested Capital changed N/A to 0.2% in Q4 2019 from the same period last year, while for Dec 2019 it was 0.2%, marking a year-over-year change of. This contributed to the annual value of 0.22% for FY2019, which is N/A changed from last year.
  • Latest data reveals that Pharma reported Return on Invested Capital of 0.2% as of Q4 2019.
  • Pharma's 5-year Return on Invested Capital high stood at 0.11% for Q3 2017, and its period low was 0.27% during Q1 2015.
  • Over the past 5 years, Pharma's median Return on Invested Capital value was 0.14% (recorded in 2016), while the average stood at 0.17%.
  • In the last 5 years, Pharma's Return on Invested Capital tumbled by -900bps in 2015 and then skyrocketed by 1300bps in 2016.
  • Quarter analysis of 5 years shows Pharma's Return on Invested Capital stood at 0.24% in 2015, then skyrocketed by 50bps to 0.12% in 2016, then grew by 14bps to 0.11% in 2017, then decreased by -6bps to 0.11% in 2018, then tumbled by -80bps to 0.2% in 2019.
  • Its last three reported values are 0.2% in Q4 2019, 0.19% for Q3 2019, and 0.17% during Q2 2019.